1887

Chapter 2 : Enterovirus Genetics

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Enterovirus Genetics, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818326/9781555810924_Chap02-1.gif /docserver/preview/fulltext/10.1128/9781555818326/9781555810924_Chap02-2.gif

Abstract:

The genetic analysis of enteroviruses was revolutionized by the advent of genetic engineering techniques and more specifically by two discoveries. First, the genetic map of the poliovirus genome was determined through sequence analysis of viral RNA and virus-encoded proteins. Second, cDNA copies of picornavirus genomes were found to yield infectious virus when they were introduced into mammalian cells either as DNA or, more efficiently, as RNA transcripts. This development has permitted facile generation and analysis of mutant viruses at the molecular level. Genetic studies based on these two developments have contributed substantially to our understanding of the biology and pathogenic properties of enteroviruses. Genetic dissection of the enteroviral 5' nontranslated region (NTR) and polyprotein has been facilitated by the recent development of a strategy that involves insertion of an internal ribosomal entry site (IRES) element into the enteroviral genome. The evolutionary role of recombination in the generation of enterovirus genomes is discussed in detail in this chapter. Generation of enterovirus mutants is the first critical step in their genetic analysis. Mutants with single defined genetic alterations are preferred starting materials for genetic experiments, and they can now be generated readily by manipulation of infectious cDNA clones, and genotypes can be confirmed by recloning and sequencing. Enteroviral mutants have been generated by a variety of strategies. The chapter talks about genetic complementation, reversion, recombination, and genetics of pathogens.

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2

Key Concept Ranking

Poliovirus 2
0.47149497
Foot-and-mouth disease virus
0.4689188
Genetic Elements
0.4631299
0.47149497
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Genetic organization of poliovirus type 1 (Mahoney), the type member of genus Enterovirus of Picornaviridae. The polyprotein encoded by the single ORF is shown as an elongated rectangle, the 5' and 3' noncoding regions are shown as lines, and the genome-linked protein (VPg) is indicated by a black circle. Cleavage sites between individual viral proteins are shown above the genome at appropriate locations; these proteins are described within the rectangle according to the L434 nomenclature ( ); the capsid proteins 1AB, 1A, IB, 1C, and ID are commonly referred to as VPO, VP4, VP2, VP3, and VP1, respectively. The proteinases 2Apro, 3Cpro, and 3CDpro are represented by shaded boxes. The structural protein precursor PI and the nonstructural protein precursors P2 and P3 are indicated above the polyprotein.

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Schematic depiction of the secondary structure of the 5′ nontranslated region of poliovirus based on previous models ( ). The nomenclature of structural elements is described elsewhere ( ). Boundaries of IRES are indicated by a dotted line; the Yn and AUG elements of the Yn-Xm-AUG motif are represented by shaded and black rectangles, respectively; and the initiating codon of the viral polyprotein is represented by an open rectangle.

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Relationship among members of the Enterovirus genus, according to aligned sequences of their genomic RNAs. Relationships are presented graphically as a minimum length, binary parsimonious rooted cladogram, calculated by using heuristic methods. Abbreviations: BEV, bovine enterovirus; CoxA, coxsackie A virus; CoxB, coxsackie B virus; Echo, echovirus; EV, enterovirus; Polio, poliovirus; SVD, swine vesicular disease virus.

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Genetic organization of dicistronic poliovirus mRNA genomes.The 5'–terminal 108–nt fragment of the PV1(M) 5' NTR is shown as a cloverleaf, the downstream segments of the 5' NTR (including the IRES) are shown as thin zigzag lines, and the segments of the EMCV 5' NTR inserted into the poliovirus genome are shown as thick zigzag lines. EMCV segments correspond to nt 260 to 848 (in plasmids 1 and 4), 260 to 833 (in plasmids 5 to 11), and 435 to 833 (in plasmid 3). Stippled rectangles represent poliovirus coding regions, and the cross-hatched rectangles represent the chloramphenicol acetyltransferase (CAT) and luciferase (LUC) coding regions. Viruses recovered after transfection of mRNA transcripts into HeLa cells are described with standard nomenclature; (–) indicates that a viable virus was not recovered.

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

Complementation map of poliovirus. Deletions identified in DI particles ( ) are shown as rectangles; other mutations are shown as circles. Open circles represent recessive mutations that can be complemented by wt or other mutant viruses ( ), black circles represent as-dominant mutations that cannot be complemented or rescued ( ), and gray circles represent trans-dominant mutations that can inhibit the growth of coinfecting virus ( ). Adapted from a figure by Kirkegaard ( ).

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6
FIGURE 6

Steps in the replication of poliovirus RNA. Parental positive-sense virion RNA is transcribed in a primer-dependent manner. A replicative intermediate (RI) form (A) consisting of a single positive-sense template (solid line) and multiple nascent negative-strands (dashed lines) has not been detected, so that more probable intermediates in negative-strand synthesis could be mainly single stranded (B) or double stranded (C). Elongation of nascent negative-sense strand (C) yields RF double-stranded RNA (D).This product of replication may be an intermediate in the synthesis of positive-sense replicative intermediate structure F or G. The first step in this process may be the partial melting of RF RNA, leading to the formation of terminal cloverleaf structures; the cloverleaf formed on the positive-sense strand may be stabilized by a complex consisting of 3CDpro and host factors or other viral polypeptides (E). The final product is single-stranded positive-sense genomic virion RNA (H). The generation of free negative-sense strands is unlikely. The 5'-terminal VPg moieties are represented by solid circles.

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 7
FIGURE 7

Two models for recombination between poliovirus genomes based on proposals by Romanova et al. ( ) and (model 1) Jarvis and Kirkegaard ( ) (model 2). In model 1, self-complementary regions are denoted as a and a'. Solid lines correspond to genomic template RNA molecules, and dashed lines correspond to the complementary RNA strand. Homologous recombination sites are represented by black rectangles. Heteroduplex formation results in base pairing of two genome molecules that are brought close together (step A).The viral RNA polymerase copies one RNA molecule from the 3' end and may pause within the region of intermolecular base pairing (step B), dissociate, and reassociate with a homologous site in the second RNA molecule (step C). Synthesis of a recombinant minus-strand molecule then continues (step D). In model 2, solid lines represent genomic template RNA molecules, broken lines correspond to nascent minus strands, and dashed lines correspond to invading positive-sense template RNA molecule. The viral RNA polymerase copies one RNA molecule from the 3' end and may pause, slide backward, and unpair a few bases of the nascent strand (step A), which then associates with an invading acceptor RNA strand (step B). Synthesis of a recombinant minus-strand molecule then continues (step C).

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 8
FIGURE 8

Locations of attenuating mutations in poliovirus types 1 and 3 (Sabin) strains. (A) Locations of nucleotide and amino acid differences between the P1/Mahoney/41 (parent) and P1/LS-c, 2ab (vaccine) strains are indicated by lines above and below the genomic RNA, respectively. There are 55 nucleotide differences between the genomes of these two PV type 1 strains ( ). (B) Nucleotide and predicted amino acid sequence differences between P3/Leon/37 (parent) and P3/Leon 12afb (Sabin vaccine) poliovirus type 3 strains ( ). Genomic RNA and its genetic organization are shown at the top, and the length of the poliovirus genome from the ′' terminus is indicated at the bottom. An additional recently reported difference between these two strains ( ) at nt 2493, producing an amino acid change at residue 6 of the capsid protein VP1, is not shown.

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 9
FIGURE 9

Domain V of the 5' noncoding regions of poliovirus types 1 (Mahoney), 2 (Lansing), and 3 (Leon), based on the structure proposed by Pilipenko et al. ( ).The nucleotide substitutions that attenuate the Sabin vaccine strains of these three serotypes are circled, and their locations are indicated.

Citation: Hellen C, Wimmer E. 1995. Enterovirus Genetics, p 25-48. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818326.chap2
1. Abraham, G.,, and R. J. Colonno. 1984. Many rhinovirus serotypes share the same cellular receptor. J. Virol. 51:340345.
2. Adler, C. J.,, M. Elzinga,, and E. Wimmer. 1983. The genome-linked protein of picornavirus.VIII. Complete amino acid sequence of poliovirus VPg and carboxy-terminal analysis of its precursor, P3-9. J. Gen. Virol. 64:349355.
3. Agol, V. I.,, S. G. Drozdov,, M. R Frolova,, V. P. Grachev,, M. S. Kolesnikova,, V. G. Kozlov,, N. M. Ralph,, L. I. Romanova,, E. A. Tolskaya,, and E. G. Viktorova. 1985. Neurovirulence of the intertypic poliovirus recombinant v3/al-25: characterization of strains isolated from the spinal cord of diseased monkeys and evaluation of the contribution of the 3' half of the genome J. Gen.Virol. 66:309316.
4. Agol, V. I.,, S. G. Drozdov,, V. P. Grachev,, M. S. Kolesnikova,, V. G. Kozlov,, N. M. Ralph,, L. I. Romanova,, E. A. Tolskaya,, A. V. Tyufanov,, and E. G. Viktorova. 1985. Recombination between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points. Virology 143:467477.
5. Agol, V. I.,, V. R. Grachev,, S. G. Drozdov,, M. S. Kolesnikova,, V. G. Kozlov,, N. M. Ralph,, L. I. Romanova,, E. A. Tolskaya,, A. V. Tyufanov,, and E. G. Viktorova. 1984. Construction and properties of intertypic poliovirus recombinants: first approximate mapping of the major determinants of neurovirulence. Virology 136:4155.
6. Agol, V. I.,, and G. Shirman. 1964. Interaction of guanidine-sensitive and guanidine-dependent variants of poliovirus in mixedly infected cells. Biochem. Biophys. Res. Commun. 17:28.
7. Agut, H.,, K. M. Kean,, C. Bellocq,, O. Fichot,, and M. Girard. 1987. Intratypic recombination of polioviruses: evidence for multiple crossing-over sites on the viral genome. J. Virol. 61:17221725.
8. Agut, H.,, K. M. Kean,, O. Fichot,, J. Morasco,, J. B. Flanegan,, and M. Girard. 1989. A point mutation in the poliovirus polymerase gene determines a complementable temperature-sensitive defect of RNA replication. Virology 168:302311.
9. Ahlquist, P.,, and P. Kaesberg. 1979. Determination of the length distribution of poly (A) at the 3' terminus of the virion RNAs of EMC virus, poliovirus, rhinovirus, RAV-61 and CPMV and of mouse globin mRNA. Nucleic Acids Res. 7:11951204.
10. Alexander, H.,, G. Koch,, I. Mountain,, K. Sprunt,, and O. van Damme. 1958. Infec-tivity of ribonucleic acid of poliovirus on HeLa cell monolayers. Virology 5:172.
11. Alexander, L.,, H. H. Lu,, and E. Wimmer. 1994. Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign gene. Proc. Natl. Acad. Sci. 91:14061410.
11a. Allaire, M.,, M. M. Chermaia,, B. A. Malcolm,, and M. N. G. James. 1994. Picornaviral 3C proteinases have a fold similar to the chymotrypsin-like serine proteinases. Nature (London) 369:7276.
12. Almond, J. W. 1987. The attenuation of poliovirus neurovirulence. Annu. Rev. Microbiol. 41:153180.
13. Anderson-Sillman, K.,, S. Bartal,, and D. R. Tershak. 1984. Guanidine-resistant poliovirus mutants produce modified 37-kilodalton proteins. J. Virol. 50:922928.
14. Andino, R.,, G. E. Rieckhof,, P. L. Achahoso,, and D. Baltimore. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. EMBO J. 12:35873598.
15. Andino, R.,, G. E. Rieckhof,, and D. Baltimore. 1990. A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. Cell 63:369380.
16. Andino, R.,, G. E. Rieckhof,, D. Trono,, and D. Baltimore. 1990. Substitutions in the protease (3Cpro gene of poliovirus can suppress a mutation in the 5' noncoding region. J. Virol. 64:607612.
17. Ansardi, D. C.,, M. Luo,, and C. D. Morrow. 1994. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34.VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA. Virology 199:2034.
18. Ansardi, D. C.,, and C. D. Morrow. 1993. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation. J. Virol. 67:72847297.
19. Argos, P.,, G. Kamer,, M. J. H. Nicklin,, and E. Wimmer. 1984. Similarity in gene organization and homology between proteins of animal picornaviruses and plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res. 12:72517267.
20. Armstrong, J. A.,, M. Edmonds,, H. Nakazato,, B. A. Philips,, and M. H. Vaughan. 1972. Polyadenylic acid sequences in the virion RNA of poliovirus and eastern equine encephalitis virus. Science 176:526528.
21. Auvinnen, P.,, and T. Hyppia. 1990. Echo-viruses include genetically distinct serotypes. J. Gen. Virol. 71:21332139.
22. Auvinnen, P.,, G. Stanway,, and T. Hyppia. 1989. Genetic diversity of enterovirus subgroups. Arch. Virol. 104:175186.
23. Baltera, R. P.,, and D. R. Tershak. 1989. Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C. J. Virol. 63:44414444.
24. Baltimore, D. 1968. Structure of the poliovirus replicative intermediate RNA. J. Mol. Biol. 32:359368.
25. Baltimore, D. 1971. Expression of animal viral genomes. Bacteriol. Rev. 35:235241.
26. Baltimore, D.,, and M. Girard. 1966. An intermediate in the synthesis of poliovirus RNA. Proc. Natl. Acad. Sci. 56:741746.
27. Bazan, J. F.,, and R. F. Fletterick. 1988.Viral cysteine proteinases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc. Natl. Acad. Sci. 85:78727876.
28. Bendinelli, M.,, and H. Friedman. 1988. Coxsackieviruses: a General Update. Plenum Press, New York.
29. Benyesh, M.,, H. Itoh,, G. D. Hsiung,, and J. L. Melnick. 1957. Mixed infections between ECHO and polioviruses. Fed. Proc. 16:365.
30. Bergelson, J. M.,, M. P. Shepley,, B. M. C. Chan,, M. E. Hemler,, and R. W. Finberg. 1992. The integrin VL-2: an echovirus receptor. Science 255:17181720.
31. Bernstein, H. D.,, and D. Baltimore. 1988. Poliovirus mutant that contains a cold-sensitive defect in viral RNA synthesis. J. Virol. 62:29222928.
32. Bernstein, H. D.,, P. Sarnow,, and D. Baltimore. 1986. Genetic complementation among poliovirus mutants derived from an infectious cDNA clone. J. Virol. 60:10401049.
33. Bernstein, H. D.,, N. Sonenberg,, and D. Baltimore. 1986. Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol. Cell. Biol. 5:29132923.
34. Bienz, K.,, D. Egger,, T. Pfister,, and M. Troxler. 1992. Structural and functional characterization of the poliovirus replication complex. J. Virol. 66:27402747.
35. Bishop, J. M.,, and G. Koch. 1969. Infectious replicative intermediate of poliovirus: purification and characterization. Virology 37:521534.
36. Blackburn, R. V.,, V. R. Racaniello,, and V. F. Righthand. 1991. Construction of an infectious cDNA clone of echovirus 6. Virus Res. 22:7178.
37. Blondel, B.,, R. Crainic,, O. Fichot,, G. Dufraisse,, A. Candrea,, D. Diamond,, M. Girard,, and F. Horaud. 1986. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J. Virol. 57:8190.
38. Bodian, D.,, and D. M. Horstmann,. 1965. Polioviruses, p. 430473. In F. Horsfall, and I. Tamm (ed.), Viral and Rickettsial Diseases of Man, 4th ed. J. B. Lippincott, Philadelphia.
39. Boeye, A. 1959. Induction of mutation in poliovirus by nitrous acid. Virology 9:691700.
40. Borman, A.,, M. T. Howell,, J. G. Patton,, and R. J. Jackson. 1993. The involvement of a spliceosome component in internal initiation of human rhinovirus RNA translation. J. Gen. Virol. 74:17751788.
41. Borman, A. M.,, F. G. Deliat,, and K. M. Kean. 1994. Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J. 13:31493157.
42. Bozarkian, S.,, I. Pelletier,, V. Calvez,, and F. Colbere-Garapin. 1993. Precise missense and silent mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J. Virol. 67:29142917.
43. Burns, C. C.,, O. C. Richards,, and E. Ehrenfeld. 1992. Temperature-sensitive polioviruses containing mutations in RNA polymerase. Virology 189:568582.
44. Caggana, M.,, P. Chan,, and A. Ramsingh. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:47974803.
45. Caliguiri, L. A.,, and I. Tamm,. 1973. Guanidine and 2-(α -hydroxybenzyl)-benzimidazole (HBB): selective inhibitors of picornavirus multiplication, p. 257294. In W. Carter (ed.), Selective Inhibitors of Viral Function. CRC Press, Cleveland.
46. Cammack, N.,, A. Phillips,, G. Dunn,, V. Patel,, and P. D. Minor. 1988. Intertypic genomic rearrangements of poliovirus vaccine strains in vaccinees. Virology 167:507514.
47. Cann, A. J.,, G. Stanway,, P. J. Hughes,, P. D. Minor,, D. M. A. Evans,, G. C. Schild,, and J. W. Almond. 1984. Reversion to neurovirulence of the live attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res. 12:77877792.
48. Cao, X.-M.,, R. J. Kuhn,, and E. Wimmer. 1993. Replication of poliovirus RNA containing two VPg coding sequences leads to a specific deletion event. J. Virol. 67:55725578.
48a. Cao, X.-M.,, and E. Wimmer. Unpublished results.
49. Chang, K. H.,, P. Auvinen,, T. Hyppiä,, and G. Stanway. 1989. The nucleotide sequence of coxsackievirus A9: implications for receptor binding and enterovirus classification. J. Gen. Virol. 70:32693280.
50. Chang, K. H.,, C. Day,, J. Walker,, T. Hyppiä,, and G. Stanway. 1992. The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP 1 is functionally significant. J. Gen. Virol. 73:621626.
51. Chao, L. 1990. Fitness of RNA virus decreased by Muller's ratchet. Nature (London) 348:454455.
52. Chapman, N. M.,, Z. Tu,, S. Tracy,, and C. J. Gauntt. 1994. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of other cardiovirulent coxsackieviruses. Arch. Virol. 135:115130.
53. Charini, W. A.,, C. C. Burns,, E. Ehrenfeld,, and B. L. Semler. 1991. trans rescue of a mutant poliovirus RNA polymerase function. J. Virol. 65:26552665.
53a. Charini, W. A.,, S. Todd,, G. A. Gutman,, and B. L. Semler. 1994. Transduction of a human RNA sequence by poliovirus. J. Virol. 68:65476552.
54. Chen, B.-F.,, L.-H. Hwang,, and D. S. Chen. 1993. Characterization of a bicistronic retroviral vector composed of the swine vesicular disease virus internal ribosome entry site. J. Virol. 67:21422148.
55. Choi, W. S.,, R. Pal-Ghosh,, and C. D. Morrow. 1991. Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol and env proteins from chimeric HIV-l-poliovirus minireplicons. J. Virol. 65:28752883.
56. Choppin, P. W.,, and H. J. Eggers. 1962. Heterogeneity of coxsackievirus B4 virus: two kinds of particles which differ in antibody sensitivity, growth rate, and plaque size. Virology 18:470476.
57. Chow, M.,, J. F. E. Newman,, D. Filman,, J. M. Hogle,, D. J. Rowlands,, and F. Brown. 1987. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (London) 327:482486.
58. Christodoulou, C.,, F. Colbere-Garapin,, A. Macadam,, L. F. TafFs,, S. Marsden,, P. D. Minor,, and F. Horaud. 1990. Mapping of mutations associated with monkey neurovirulence of Sabin 1 poliovirus revertants selected at high temperature. J. Virol. 64: 49224929.
59. Chumakov, K. M.,, E. M. Dragunsky,, L. P. Norwood,, M. P. Douthitt,, Y. Ran,, R. E. Taflfs,, J. Ridge,, and I. S. Levenbrook. 1994. Consistent selection of mutations in the 5'-untranslated region of oral poliovirus vaccine upon passaging in vitro. J. Med. Virol. 42:7985.
60. Chumakov, K. M.,, L. P. Norwood,, M. Parker,, E. Dragunsky,, R. TafFs,, Y. Ran,, J. Ridge,, and I. Levenbrook. 1992. RNA sequence variants in live poliovaccine and their relation to neurovirulence. J. Virol. 66:966970.
61. Chumakov, K. M.,, L. B. Powers,, K. E. Noonan,, I. B. Roninson,, and I. S. Levenbrook. 1991. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptance of oral poliovaccine. Proc. Natl. Acad. Sci. 88:199203.
62. Colbere-Garapin, P.,, C. Christodolou,, R. Crainic,, and I. Pelletier. 1989. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. 86:75907594.
63. Cole, C. N.,, and D. Baltimore. 1973. Defective interfering particles of poliovirus. II. Nature of the defect. J. Mol. Biol. 76:325343.
64. Collis, P. S.,, B. J. O'Donnell,, D. J. Barton,, J. A. Rogers,, and J. B. Flanegan. 1992. Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. J. Virol. 66:64806488.
65. Colter, J. S.,, H. H. Bird,, A. W. Moyer,, and R. A. Brown. 1957. Infectivity of ribonucleic acid from virus infected tissues Virology 4:522.
66. Compton, S. R.,, B. Nelsen,, and K. Kirkegaard. 1990. Temperature-sensitive poliovirus mutant fails to cleave VPO and accumulates provirions. J. Virol. 64:40674075.
67. Cooper, P. D. 1965. Rescue of one phenotype in mixed infections with heat-defective mutants of poliovirus type 1. Virology 25:431438.
68. Cooper, P. D. 1968. A genetic map of poliovirus temperature-sensitive mutants. Virology 35:584596.
69. Cooper, P. D. 1977. Genetics of picornaviruses. Comp. Virol. 9:133207.
70. Cords, C. E.,, and J. J. Holland. 1964. Replication of poliovirus RNA induced by a heterologous virus. Proc. Natl. Acad. Sci. 51:10801082.
71. Cords, C. E.,, and J. J. Holland. 1964. Alteration of the species and tissue specificity of poliovirus by enclosure of its RNA within the protein capsid of coxsackie Bl virus. Virology 24:492495.
72. Couderc, T.,, J. Hogle,, H. Le Blay,, F. Horaud,, and B. Blondel. 1993. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell. J. Virol. 67:38083817.
72a. Crowell, R. L.,, and J. T. Syverton. 1961. The mammalian cell-virus relationship. VI. Sustained infection of HeLa cells by coxsackievirus B3 virus and effect on superinfection. J. Exp. Med. 113:419435.
73. Crowther, D.,, and J. L. Melnick. 1961. Studies on the inhibitory action of guanidine on poliovirus multiplication in cell cultures. Virology 15:6574.
74. Cui, T.,, S. Sankar,, and A. G. Porter. 1994. Binding of EMC virus RNA polymerase to the 3'-noncoding region of the viral RNA is specific and requires the 3'-poly(A) tail. J. Biol. Chem. 268:2609326098.
75. Dalldorf, G. 1950. The Coxsackie viruses. Bull. N.Y.Acad. Med. 26:329335.
76. Darnell, J. E.,, and H. Eagle. 1960. The biosynthesis of poliovirus in cell cultures. Adv. Virus Res. 6:126.
77. Dasgupta, A.,, M. H. Baron,, and D. Baltimore. 1979. Poliovirus replicase: a soluble enzyme able to initiate copying of poliovirus RNA. Proc. Natl. Acad. Sci. 76:26792683.
78. Del Angel, R. M.,, A. G. Papavassilou,, C. Fernandez-Thomas,, S. J. Silverstein,, and V. R. Racaniello. 1989. Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc. Natl. Acad. Sci. 86:82998303.
79. Delarue, M.,, O. Poch,, N. Tordo,, D. Moras,, and P. Argos. 1990. An attempt to unify the structure of polymerases. Protein Eng. 3:461467.
80. de la Torre, J. C.,, C. Giachetti,, B. L. Semler,, and J. J. Holland. 1992. High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc. Natl. Acad. Sci. 89:23512355.
81. de la Torre, J. C.,, and J. J. Holland. 1990. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64:62786281.
82. de la Torre, J. C.,, E. Wimmer,, and J. J. Holland. 1990. Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J. Virol. 64:664671.
83. Dever, T. E.,, M. J. Glynias,, and W. C. Merrick. 1987. GTP-binding domain: three consensus sequence elements with distinct spacing. Proc. Natl. Acad. Sci. 84:18141818.
84. Dewalt, P. G.,, W. S. Blair,, and B. L. Semler. 1989. A genetic locus in mutant poliovirus genomes involved in over-production of RNA polymerase and 3C proteinase. Virology 174:504514.
85. Dewalt, P. G.,, and B. L. Semler. 1987. Site-directed mutagenesis of proteinase 3C results in a poliovirus deficient in synthesis of viral RNA polymerase. J. Virol. 61:21622170.
86. Diamond, D.,, B. A. Jameson,, J. Bonin,, M. Kohara,, S. Abe,, H. Itoh,, T. Komatsu,, M. Arita,, S. Kuge,, A. Nomoto,, A. D. M. E. Osterhaus,, R. Crainic,, and E. Wimmer. 1985. Antigenic variation and resistance to neutralization of poliovirus type 1. Science 229:10901093.
87. Diamond, S. E.,, and K. Kirkegaard. 1994. Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis. J. Virol. 68:863876.
88. Dildine, S.,, and B. L. Semler. 1989. The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5' noncoding region of genomic RNA. J. Virol. 63:847862.
89. Domier, L. L.,, J. G. Shaw,, and R. E. Rhoads. 1987. Potyviral proteins share amino acid sequence homology with picorna-, como-, and caulimoviral proteins. Virology 158:2027.
90. Domingo, E.,, E. Martinez-Salas,, F. Sobrino,, J. C. de la Torre,, A. Portela,, J. Ortin,, C. Lopez-Galindez,, P. Peres-Brena,, N. Villanueva,, R. Najera,, S. VandePol,, D. Steinhauer,, N. DePolo,, and J. J. Holland. 1985. The quasispecies (extremely heterogenous) nature of viral RNA genome populations: biological relevance—a review. Gene 40:18.
91. Dorner, A. J.,, L. F. Dorner,, G. R. Larsen,, E. Wimmer,, and C. W. Anderson. 1982. Identification of the initiation site of poliovirus polyprotein synthesis. J. Virol. 42: 10171028.
92. Dorner, A. J.,, B. L. Semler,, R. J. Jackson,, R. Hanecak,, E. Duprey,, and E. Wimmer. 1984. In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J. Virol. 50:507514.
93. Dorsch-Haesler, K.,, Y. Yogo,, and E. Wimmer. 1975. Replication of picornaviruses. I. Evidence from in vitro RNA synthesis that poly(A) of the poliovirus genome is genetically coded J. Virol. 16:15121517.
94. Drake, J. W. 1993. Rates of spontaneous mutation among RNA viruses. Proc. Natl. Acad. Sci. 90:41714175.
95. Dreano, M. C.,, C. Bellocq,, O. Fichot,, S. van der Werf,, and M. Girard. 1985. Genetic variations in the Mahoney strain of poliovirus type 1. Ann. Inst. Pasteur/Virol. 136:102114.
96. Duarte, E. A.,, D. K. Clarke,, A. Moya,, S. F. Elena,, E. Domingo,, and J. J. Holland. 1993. Many-trillionfold amplifications of single RNA virus particles fail to overcome the Miiller's ratchet effect. J. Virol. 67:36203623.
97. Duarte, E. A.,, I. S. Novella,, S. Ledesma,, D. K. Clarke,, A. Moya,, S. F. Elena,, E. Domingo,, and J. J. Holland. 1994. Subclonal components of consensus fitness in an RNA virus clone. J. Virol. 68:42954301.
98. Dulbecco, R. 1952. Production of plaques in monolayer tissue cultures by single particles of an animal virus. Proc. Natl. Acad. Sci. 38:747752.
99. Dulbecco, R.,, and M. Vogt. 1954. Plaque formation and isolation of pure lines with poliomyelitis viruses. J. Exp. Med. 99:167182.
100. Duncan, I. R. B. 1968. A comparative study of 63 strains of ECHO virus type 30. Arch. Ges. Virusforsch. 25:93104.
101. Dunn, G.,, N. T. Begg,, N. Cammack,, and P. D. Minor. 1990. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J. Med. Virol. 32:9295.
102. Earle, J. A. P.,, R. A. Skuce,, C. S. Fleming,, E. M. Hoey,, and S.J. Martin. 1988. The complete nucleotide sequence of a bovine enterovirus. J. Gen. Virol. 69:253263.
103. Eggers, H. J.,, and A. B. Sabin. 1959. Factors determining pathogenicity of variants of ECHO 9 virus for newborn mice. J. Exp. Med. 110:951967.
104. Eggers, H. J.,, and I. Tamm. 1962. On the mechanism of selective inhibition of enterovirus multiplication by 2-(a-hydroxybenzyl)-benzimidazole. Virology 18:426438.
105. Eigen, M.,, and C. K. Biebricher,. 1988. Sequence space and quasispecies distribution, p. 211245. In E. Domingo,, J. J. Holland,, and R. Ahlquist (ed.), RNA Genetics, vol. 3. CRC Press, Boca Raton.
106. Emini, E.,, M. Elzinga,, and E. Wimmer. 1982. Carboxy-terminal analysis of poliovirus proteins: termination of poliovirus RNA translation and location of unique poliovirus polyprotein cleavage sites. J. Virol. 42:194199.
106a. Emini, E. A.,, B. A. Jameson,, A. J. Lewis,, G. R. Larsen,, and E. Wimmer. 1982. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J. Virol. 43:9971005.
107. Emini, E.,, S. Y. Kao,, A. J. Lewis,, R. Crainic,, and E. Wimmer. 1983. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. J. Virol. 46:466474.
107a. Emini, E. A.,, J. Leibowitz,, D. C. Diamond,, J. Bonin,, and E. Wimmer. 1984. Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro pheno-typic markers and evidence that resistance to guanidine maps in the nonstructural proteins. Virology 137:7485.
108. Enders, J. F.,, T. H. Weller,, and F. C. Robbins. 1949. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109:8587.
109. Enders, J. F.,, T. H. Weller,, and F. C. Robbins. 1952. Alteration in pathogenicity of Brunhilde strain of poliomyelitis virus following cultivation in human tissues. Fed. Proc. 11:467.
110. Equestre, M.,, D. Genovese,, F. Valiere,, L. Fiore,, R. Santoro,, and R. Perez-Bercoff. 1991. Identification of a consistent pattern of mutations in neurovirulent variants derived from the Sabin vaccine strain of poliovirus type 2. J. Virol. 65:27072710.
111. Evans, D. M.,, G. Dunn,, P. D. Minor,, G. C. Schild,, A. J. Cann,, G. Stanway,, J. W. Almond,, K. Currey,, and J. V. Maizel. 1985. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (London) 314:548550.
112. Filman, D. J.,, R. Syed,, M. Chow,, A. J. Macadam,, P. D. Minor,, and J. M. Hogle. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:15671579.
113. Flanegan, J. B.,, R. F. Petterssori,, V. Ambros,, M. J. Hewlett,, and D. Baltimore. 1977. Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus. Proc. Natl. Acad. Sci. 74:961965.
114. Franssen, H.,, J. Leunissen,, R. Goldbach,, G.P. Lomonossoff,, and D. Zimmern. 1984. Homologous sequences in non-structural proteins from cowpea mosaic virus and picornaviruses. EMBO J. 3:855861.
115. Furione, M.,, S. Guillot,, D. Otelea,, J. Balanant,, A. Candrea,, and R. Crainic. 1993. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196:199208.
116. Gauntt, C. J.,, M. D. Trousdale,, D. R. L. LaBadie,, R. E. Paque,, and T. Nealon. 1979. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J. Med. Virol. 3:207220.
117. Giachetti, C.,, S. S. Hwang,, and B. L. Semler. 1992. cis-Acting lesions targeted to the hydrophobic domain of a poliovirus membrane protein involved in RNA replication. J. Virol. 66:60456057.
118. Giachetti, C.,, and B. L. Semler. 1991. Role of a viral membrane polypeptide in strand-specific initiation of poliovirus RNA synthesis. J. Virol. 65:26472654.
119. Gmyl, A. P.,, E. V. Pilipenko,, S. V. Maslova,, G. A. Belov,, and V. I. Agol. 1993. Functional and genetic plasticities of the poliovirus genome: quasi-infectious RNAs modified in the 5'-untranslated region yield a variety of pseudorevertants. J. Virol. 67:63096316.
120. Gorbalenya, A. E.,, V. M. Blinov,, and E. Koonin. 1985. Prediction of nucleotide-bind-ing properties of virus-specific proteins from their primary structure. Mol. Genet. 11:3036.
121. Gorbalenya, A. E.,, A. P. Donchenko,, V. M. Blinov,, and E. Koonin. 1989. Cysteine proteases of positive strand RNA viruses and chymotrypsin-like serine proteases. A distinct protein superfamily with a distinct protein fold. FEBS Lett. 243:103114.
122. Gratsch, T. E.,, and V. F. Righthand. 1994. Construction of a recombinant cDNA of echovirus 6 that established a persistent in vitro infection. Virology 201:341348.
123. Grist, N. R.,, E.J. Bell,, and F. Assad. 1978. Enteroviruses in human disease. Prog. Med. Virol. 24:114157.
124. Hagino-Yamagishi, K.,, and A. Nomoto. 1989. In vitro construction of poliovirus defective interfering particles. J. Virol. 63:53865392.
125. Haller, A. A.,, J. H. C. Nguyen,, and B. L. Semler. 1994. Minimum internal ribosome entry site required for poliovirus infectivity. J. Virol. 67:74617471.
126. Haller, A. A.,, and B. L. Semler. 1992. Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA. J. Virol. 66:50755086.
127. Hammerle, T.,, C. U. T. Hellen,, and E. Wimmer. 1991. Site-directed mutagenesis of the catalytic triad of poliovirus 3C proteinase. J. Biol. Chem. 266:54125416.
128. Hammerle, T.,, A. Molla,, and E. Wimmer. 1992. Mutational analysis of the proposed FG loop of poliovirus proteinase 3C identifies amino acids that are necessary for 3CD cleavage and might be determinants of a function distinct from proteolytic activity. J. Virol.66:60286034.
129. Hanecak, R.,, B. L. Semler,, C. W. Anderson,, and E. Wimmer. 1982. Preoteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc. Natl. Acad. Sci. 79:39733977.
130. Harmon, S. A.,, O. C. Richards,, D. F. Summers,, and E. Ehrenfeld. 1991. The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J. Virol. 65:27572760.
131. Harris, K. S.,, C. U. T. Hellen,, and E. Wimmer. 1990. Proteolytic processing in the replication of picornaviruses. Semin. Virol. 1:323333.
132. Harris, K. S.,, W. Xiang,, L. Alexander,, W. C. Lane,, A. V. Paul,, and E. Wimmer. 1994. Interaction of the polioviral polypeptide 3CDpro with the 5' and 3' termini of the poliovirus genome: identification of viral and cellular cofactors needed for efficient binding. J. Biol. Chem. 269:2700427014.
133. Hatfield, G. W.,, and G. A. Gutman,. 1993. Codon pair utilization bias in bacteria, yeast, and mammals, p. 157189. In D. L. Hatfield,, B. J. Lee,, and R. M. Pirtle (ed.), Transfer RNA in Protein Synthesis. CRC Press, Inc., Boca Raton, Fla.
134. Hellen, C. U. T.,, H.-G. Kräusslich,, and E. Wimmer. 1989. Proteolytic processing of polyprotein in the replication of RNA viruses. Biochemistry 28:98819890.
135. Hellen, C. U. T.,, T.V. Pestova,, M. Litterst,, and E. Wimmer. 1994. The cellular polypeptide p57 (pyrimidine-tract binding protein) binds to multiple sites in the poliovirus 5' nontranslated region. J. Virol. 68:941950.
136. Hellen, C. U. T.,, T. V. Pestova,, and E. Wimmer. 1994. Effect of mutations downstream of the internal ribosome entry site on initiation of poliovirus protein synthesis. J. Virol. 68:63126322.
137. Hellen, C. U. T.,, G. W. Witherell,, M. Schmidt,, S. H. Shin,, T. V. Pestova,, A. Gil,, and E. Wimmer. 1993. A cytoplasmic 57kDa protein (p57) that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine-tract binding protein. Proc. Natl. Acad. Sci. 90:76427646.
138. Hewlett, M. J.,, and R. Z. Florkiewicz. 1980. Sequence of picornavirus RNAs containing a radioiodinated 5'-linked peptide reveals a conserved 5' sequence. Proc. Natl. Acad. Sci. 77:303307.
139. Hewlett, S.,, S. Rosenblatt, V Ambros, and D. Baltimore. 1977. Separation and quantitation of intracellular forms of poliovirus RAN by agarose gel electrophoresis. Biochemistry 16:27632767.
140. Hirst, G. 1962. Genetic recombination with Newcastle disease virus, polioviruses and influenza. Cold Spring Harbor Symp. Quant. Biol. 27:303308.
141. Hogle, J. M.,, M. Chow,, and D. J. Filman. 1985. The three-dimensional structure of poliovirus at 2.9Å resolution. Science 229: 13581365.
142. Hogle, J. M.,, and D. J. Filman. 1989. The antigenic structure of poliovirus. Phil. Trans. R. Soc. Lond. Ser. B 323:467478.
143. Holland, J.,, J. C. de la Torre,, and D. A. Steinhauer. 1990. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:120.
144. Holland, J.,, E. Domingo,, J. C. de la Torre,, and D. A. Steinhauer. 1990. Mutation frequencies at defined single codon sites in vesicular stomatitis virus can be increased only slightly by chemical mutagenesis. J. Virol. 64:39603962.
145. Holland, J.,, L. C. McLaren,, and J. T. Syverton. 1959. The mammalian cell-virus relationship. IV Infection of naturally insusceptible cells with enterovirus ribonucleic acid. J. Exp. Med. 110:6580.
146. Holland, J.,, L. C. McLaren,, and J. T. Syverton. 1959. The mammalian cell-virus relationship. III. Non-primate cells exposed to poliovirus ribonucleic acid. Proc. Soc. Exp. Biol. Med. 100:843845.
147. Holland, J.,, K. Spindler,, F. Horodyski,, B. Garabau,, S. Nichol,, and S. Vandenpol. 1982. Rapid evolution of RNA genomes. Science 215:15771585.
148. Holland, J. J. 1961. Receptor affinities as major determinants of enterovirus tissue tropism in humans. Virology 15:312326.
149. Holland, J. J.,, and C. E. Cords. 1964. Maturation of poliovirus RNA with capsid protein coded by heterologous enteroviruses. Proc. Natl. Acad. Sci. 51:10821085.
150. Hsiung, G. D.,, and J. L. Melnick. 1957. Morphologic characteristics of plaques produced on monkey kidney monolayer cultures by enteric viruses (poliomyelitis, Coxsackie, and ECHO groups). J. Immunol. 78:128136.
151. Hsiung, G. D.,, and J. L. Melnick. 1957. Comparative susceptibility of kidney cells from different monkey species to enteric viruses (poliomyelitis, Coxsackie, and ECHO groups). J. Immunol. 78:137146.
152. Huang, A. S. 1973. Defective interfering viruses. Annu. Rev. Microbiol. 27:101117.
153. Hughes, M. S.,, E. M. Hoey,, and P. V. Coyle. 1993. A nucleotide sequence comparison of coxsackievirus B4 isolates from aquatic samples and clinical specimens. Epidemiol. Infect. 110:389398.
154. Hughes, P. J.,, D. M. A. Evans,, P. D. Minor,, G. C. Schild,, J. W. Almond,, and G. Stanway. 1986. The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland. J. Gen. Virol. 67:20932102.
155. Hughes, P. J.,, C. North,, P. D. Minor,, and G. Stairway. 1989. The complete nucleotide sequence of coxsackievirus A21. J. Gen. Virol. 70:29432952.
156. Hughes, P. J.,, A. Phillips,, P. D. Minor,, and G. Stanway. 1987. The sequence of the coxsackievirus A21 polymerase gene indicates a remarkably close relationship to the poliovirus. Arch. Virol. 94:141147.
156a. Huovilainen, A.,, T. Hovi,, L. Kinnunen,, K. Takkinen,, M. Ferguson,, and P. Minor. 1987. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. J. Gen. Virol. 68:13731378.
157. Huovilainen, A.,, L. Kinnunen,, T. Pöyry,, L. Laaksonen,, M. Roivainen,, and T. Hovi. 1994. Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins. Virology 199:228232.
158. Hyppia, T.,, C. Horsnell,, M. Maaronen,, M. Khan,, N. Kalkkinen,, T. Auvinen,, L. Kinnunen,, and G. Stanway. 1992. A distinct picornavirus group identified by sequence analysis. Proc. Natl. Acad. Sci. 89: 88478851.
159. Hyppia, T.,, and G. Stanway. 1992. Biology of coxsackie A viruses. Adv. Virus. Res. 42:343373.
160. Iizuka, N.,, M. Kohara,, M.,, K. Hagino-Yamagishi,, S. Abe,, T. Komatsu,, K. Tago,, M. Arita,, and A. Nomoto. 1989. Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J. Virol. 63:53545363.
161. Iizuka, N.,, S. Kuge,, and A. Nomoto. 1987. Complete nucleotide sequence of the genome of coxsackievirus B1. Virology 156:6473.
162. Iizuka, N.,, H. Yonekawa,, and A. Nomoto. 1991. Nucleotide sequences important for translation initiation of enterovirus RNA. J. Virol. 65:48674873.
163. Ikegami, N.,, H. J. Eggers,, and I. Tamm. 1964. Rescue of drug-requiring and drug-inhibited enteroviruses. Proc. Natl. Acad. Sci. 52:14191426.
164. Inoue, T.,, T. Suzuki,, and K. Sekiguchi. 1989. The complete nucleotide sequence of swine vesicular disease virus. J. Gen. Virol. 70:919934.
165. Inoue, T.,, S. Yamaguchi,, T. Kanno,, S. Sugita,, and T. Saeki. 1993. The complete nucleotide sequence of a pathogenic swine vesicular disease virus isolated in Japan (J1 '73) and phylogenetic analysis. Nucleic Acids Res. 21:3896.
166. Ishiko, H.,, N. Takeda,, K. Miyamura,, N. Kato,, M. Tanimura,, K. H. Lin,, M. Yin-Murphy,, J. S. Tarn,, G. F. Mu,, and S. Yamazaki. 1992. Phylogenetic analysis of a coxsackievirus A24 variant: the most recent worldwide pandemic was caused by progenies of a common virus prevalent around 1981. Virology 187:748759.
167. Ishiko, H.,, N. Takeda,, K. Miyamura,, M. Tanimura,, T. Yamanaka,, K. Kasuga,, K. Oda,, K. Imai,, Y. Yamamoto,, Y. Mochida,, K. Uchida,, H. Nakagawa,, and S. Yamazaki. 1992. Phylogenetically different strains of a variant of coxsackievirus A24 were repeatedly introduced but discontinuously circulating in Japan. Arch. Virol. 126:179193.
168. Itoh, H.,, and J. D. Melnick. 1959. Double infections of single cells with ECHO 7 and coxsackie A9 viruses. J. Exp. Med. 109:393406.
169. Jablonski, S. A.,, M. Luo,, and C. D. Morrow. 1991. Enzymatic activity of poliovirus RNA polymerase mutants with single amino acid changes in the conserved YGDD amino acid motif. J. Virol. 65:45654572.
170. Jablonski, S. A.,, and C. D. Morrow. 1993. Enzymatic activity of poliovirus RNA polymerases with mutations at the tyrosine residue of the conserved YGDD motif: isolation and characterization of polioviruses containing RNA polymerases with FGDD and MGDD sequences. J. Virol. 67:373381.
171. Jackson, R. J.,, and N. Standart. 1990. Do the poly(A) tail and 3' untranslated region control mRNA translation? Cell 62:1524.
172. Jacobson, M. F.,, and D. Baltimore. 1968. Polypeptide cleavages in the formation of poliovirus proteins. Proc. Natl. Acad. Sci. 61:7784.
173. Jacobson, S. J.,, D. A. M. Konings,, and P. Sarnow. 1993. Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification. J. Virol. 67:29612971.
174. Jang, S. K.,, H.-G. Kräusslich,, M. J. H. Nicklin,, G. M. Duke,, A. C. Palmenberg,, and E. Wimmer. 1988. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62:26362643.
175. Jang, S. K.,, T.V. Pestova,, C. U. T. Hellen,, G. W. Witherell,, and E. Wimmer. 1990. Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme 44:292309.
176. Jarvis, T. C.,, and K. Kirkegaard. 1991. The polymerase in its labyrinth. Trends Genet. 7:186191.
177. Jarvis, T. C.,, and K. Kirkegaard. 1992. Poliovirus RNA recombination: mechanistic studies in the absence of selection. EMBO J. 11:31353145.
178. Jenkins, O.,, J. D. Booth,, P. D. Minor,, and J. W. Almond. 1987. The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae. J. Gen. Virol. 68:18351848.
179. Johnson, K. L.,, and P. Sarnow. 1991. Three poliovirus 2B mutants exhibit noncomple-mentable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus. J. Virol. 65:43414349.
180. Johnson, V. H.,, and B. L. Semler. 1988. Defined recombinants of poliovirus and coxsackievirus: sequence-specific deletions and functional substitutions in the 5'-noncoding regions of viral RNAs. Virology 162:4757.
181. Jore, J.,, B. de Geus,, R. J. Jackson,, P. H. Pouwels,, and B. E. Enger-Valk. 1988. Poliovirus protein 3CD is the active protease for processing of the precursor protein P1 in vitro. J. Gen. Virol. 69:16271636.
182. Kajigaya, S.,, H. Arakawa,, S. Kuge,, T. Koi,, N. Imura,, and A. Nomoto. 1985. Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain. Virology 142:307316.
183. Kamitsuka, P. S.,, T. Y. Lon,, A. Fabiyi,, and H. A. Wenner. 1965. Preparation and standardization of coxsackievirus reference antisera. I. For twenty-four group A viruses. Am. J. Epidemiol. 81:283305.
184. Kandolf, R.,, and P. H. Hofschneider. 1985. Molecular cloning of the genome of cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc. Natl. Acad. Sci. 82:48184822.
185. Kaplan, G.,, D. Peters,, and V. R. Racaniello. 1990. Poliovirus mutants resistant to neutralization with soluble cell receptors. Science 250:15961599.
186. Kaplan, G.,, and V. R. Racaniello. 1988. Construction and characterization of poliovirus subgenomic replicons. J. Virol. 62: 16871696.
187. Kawamura, N.,, M. Kohara,, S. Abe,, T. Komatsu,, K. Tago,, M. Arita,, and A. Nomoto. 1989. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 63:13021309.
187a. Kean, K. M.,, H. Agut,, O. Fichot,, E. Wimmer,, and M. Girard. 1988. A poliovirus mutant defective for self-cleavage at the COH-terminus of the 3C protease exhibits secondary processing defects. Virology 163:330340.
188. Kean, K. M.,, N. L. Teterina,, D. Marc,, and M. Girard. 1991. Analysis of the putative active site residues of the poliovirus 3C proteinase. Virology 181:330340.
189. Kew, O. M.,, and B. K. Nottay,. 1984. Evolution of the oral polio vaccine in humans occurs by both mutation and intramolecular recombination, p. 357362. In R. A. Lerner,, R. M. Chanock,, and F. Brown (ed.), Vaccines '86. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
190. Kew, O. M.,, B. K. Nottay,, M. H. Hatch,, J. H. Nakano,, and J. F. Obijeski. 1981. Multiple genetic changes can occur in oral polio vaccines upon replication in humans. J. Gen. Virol. 56:337347.
191. Kew, O. M.,, M. Pallansch,, B. K. Nottay,, R. Rico-Hesse,, L. De,, and D. L. Yang,. 1990. Genotypic relationships among wild polioviruses from different regions of the world, p. 357365. In M. A. Brinton, and E. X. Heinz (ed.), New Aspects of Positive-Strand Viruses. American Society for Microbiology, Washington, D.C.
192. Khatchikian, D.,, M. Orlich,, and R. Rott. 1989. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature (London) 340:156157.
193. King, A. M. Q. 1988. Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences. Nucleic Acids Res. 16:1170511723.
194. King, A. M. Q.,, D. McCahon,, W. R. Slade,, and J. W. I. Newman. 1982. Recombination in RNA. Cell 29:921928.
195. King, L. A. 1986. Molecular biology of insect picornaviruses. Ph.D. thesis. University of Oxford, Oxford, United Kingdom.
196. King, L. A.,, J. S. K. Pullin,, G. Stanway,, J. W. Almond,, and N. F. Moore. 1987. Cloning of the genome of cricket paralysis virus: sequence of the 3' end. Virus Res. 6:331344.
197. Kirkegaard, K. 1990. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J. Virol. 64:195206.
198. Kirkegaard, K. 1992. Genetic analysis of picornaviruses. Curr. Top. Genet. Dev. 2:6470.
199. Kirkegaard, K.,, and D. Baltimore. 1986. The mechanism of RNA recombination in poliovirus. Cell 47:433443.
200. Kirkegaard, K.,, and B. Nelsen. 1990. Conditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA. J. Virol. 64:185194.
201. Kitamura, N.,, C. Adler,, J. Martinko,, S. Nathenson,, and E. Wimmer. 1980. The genome-linked protein of picornaviruses. VII. Genetic mapping of poliovirus VPg by protein and RNA sequence studies. Cell 21:295302.
202. Kitamura, N.,, B. L. Semler,, P. G. Rothberg,, G. R. Larsen,, C. J. Adler,, A. J. Dorner,, E. A. Emini,, R. Hanecak,, J. Lee,, S. van der Werf,, C. W. Anderson,, and E. Wimmer. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (London) 291:547553.
203. Klingel, K.,, C. Hohenadl,, A. Canu,, M. Albrecht,, M. Seemann,, G. Mall,, and R. Kandolf. 1992. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. 89:314318.
204. Klump, W. M.,, I. Bergmann,, B. C. Miiller,, D. Ameis,, and